BioCentury | Jul 8, 2019
Financial News

On heels of series C extension, RAPT Therapeutics files for IPO

...C round last month. RAPT’s stakeholders include The Column Group (34.7%), KPCB Holdings Inc. (20%), Topspin Fund...
BioCentury | Feb 22, 2019
Financial News

Peloton planning Phase III kidney cancer study with $150M series E

...Ventures, Curative Ventures and Driehaus Capital Management. Returning investors included The Column Group, Nextech Invest, Topspin Fund...
BioCentury | Feb 20, 2019
Financial News

Peloton planning Phase III kidney cancer study with $150M series E

...Ventures, Curative Ventures and Driehaus Capital Management. Returning investors included The Column Group, Nextech Invest, Topspin Fund...
BioCentury | Oct 5, 2018
Financial News

New IPO filings include NGM, Arog, Gamida

...Column Group is NGM's largest shareholder with 25%. Merck owns 16%, while Prospect Ventures and Topspin Fund...
BioCentury | Oct 1, 2018
Financial News

New IPO filings include NGM, Arog, Gamida

...Column Group is NGM's largest shareholder with 25%. Merck owns 16%, while Prospect Ventures and Topspin Fund...
BioCentury | Feb 23, 2018
Financial News

Oric raises $50M series C

...& Research, Trinitas Capital, Taiho Ventures and NS Investment. Existing investors, including The Column Group, Topspin Fund...
BioCentury | Feb 21, 2018
Financial News

Oric raises $50M series C

...& Research, Trinitas Capital, Taiho Ventures and NS Investment. Existing investors, including The Column Group, Topspin Fund...
BioCentury | Aug 10, 2017
Emerging Company Profile

Flexing against suppression

...retained Flexus’ investors Kleiner Perkins Caufield & Byers , The Column Group, Celgene Corp. and Topspin Fund...
...$79 million Investors: Kleiner Perkins Caufield & Byers , The Column Group, Celgene Corp. , Topspin Fund...
BioCentury | Mar 14, 2017
Financial News

Peloton adds $22.2M to series D round

...BioCentury Extra, Sept. 15, 2016) . Foresite Capital Management, Remeditex, The Column Group, Tichenor Ventures, Topspin Fund...
BioCentury | Sep 19, 2016
Financial News

Peloton Therapeutics completes venture financing

...Raised: $52.4 million Investors: Foresite Capital Management; Remeditex Ventures; The Column Group; Tichenor Ventures LLC; Topspin Fund...
Items per page:
1 - 10 of 22
BioCentury | Jul 8, 2019
Financial News

On heels of series C extension, RAPT Therapeutics files for IPO

...C round last month. RAPT’s stakeholders include The Column Group (34.7%), KPCB Holdings Inc. (20%), Topspin Fund...
BioCentury | Feb 22, 2019
Financial News

Peloton planning Phase III kidney cancer study with $150M series E

...Ventures, Curative Ventures and Driehaus Capital Management. Returning investors included The Column Group, Nextech Invest, Topspin Fund...
BioCentury | Feb 20, 2019
Financial News

Peloton planning Phase III kidney cancer study with $150M series E

...Ventures, Curative Ventures and Driehaus Capital Management. Returning investors included The Column Group, Nextech Invest, Topspin Fund...
BioCentury | Oct 5, 2018
Financial News

New IPO filings include NGM, Arog, Gamida

...Column Group is NGM's largest shareholder with 25%. Merck owns 16%, while Prospect Ventures and Topspin Fund...
BioCentury | Oct 1, 2018
Financial News

New IPO filings include NGM, Arog, Gamida

...Column Group is NGM's largest shareholder with 25%. Merck owns 16%, while Prospect Ventures and Topspin Fund...
BioCentury | Feb 23, 2018
Financial News

Oric raises $50M series C

...& Research, Trinitas Capital, Taiho Ventures and NS Investment. Existing investors, including The Column Group, Topspin Fund...
BioCentury | Feb 21, 2018
Financial News

Oric raises $50M series C

...& Research, Trinitas Capital, Taiho Ventures and NS Investment. Existing investors, including The Column Group, Topspin Fund...
BioCentury | Aug 10, 2017
Emerging Company Profile

Flexing against suppression

...retained Flexus’ investors Kleiner Perkins Caufield & Byers , The Column Group, Celgene Corp. and Topspin Fund...
...$79 million Investors: Kleiner Perkins Caufield & Byers , The Column Group, Celgene Corp. , Topspin Fund...
BioCentury | Mar 14, 2017
Financial News

Peloton adds $22.2M to series D round

...BioCentury Extra, Sept. 15, 2016) . Foresite Capital Management, Remeditex, The Column Group, Tichenor Ventures, Topspin Fund...
BioCentury | Sep 19, 2016
Financial News

Peloton Therapeutics completes venture financing

...Raised: $52.4 million Investors: Foresite Capital Management; Remeditex Ventures; The Column Group; Tichenor Ventures LLC; Topspin Fund...
Items per page:
1 - 10 of 22